| Literature DB >> 19564901 |
Abstract
Entities:
Mesh:
Substances:
Year: 2009 PMID: 19564901 PMCID: PMC2696089 DOI: 10.1371/journal.pbio.1000142
Source DB: PubMed Journal: PLoS Biol ISSN: 1544-9173 Impact factor: 8.029
Figure 1The actin cytoskeleton in lamellipodia and filopodia.
(A) Diagram of a growth cone. The axon shaft and growth cone body are represented by dark purple. The thinner lamellipodial and filopodial extensions are indicated by light purple. (B) Schematic diagram of the actin cytoskeleton in a region of lamellipodium containing a filopodium. Actin filaments are indicated by green triangles, with the flat end of the triangle representing the plus or barbed end of the actin filament. The plasma membrane is indicated by a black line. Actin filaments in the lamellipodium are nucleated by Arp2/3 (blue circles) at 70° angles from an existing filament and by non-Arp2/3 factors (blue diamond). Actin filaments are capped by actin-capping proteins, such as Eps8 (red stop signs). Anti-capping proteins, such as Enabled (yellow diamonds), displace capping proteins and allow actin filaments to achieve greater lengths and protrude into filopodial extensions, in which actin filaments are bundled by actin-bundling proteins (black circles).
Figure 2BDNF and MAPK inhibit Eps8, allowing for localized filopodia formation.
(A) In the absence of BDNF, Eps8 is an active capping protein that prevents the formation of long filopodial actin filaments. (B) BDNF (gray circle) is detected by Trk receptor tyrosine kinases, which locally activate MAPK signaling. MAPK activation results in phosphorylation (red “P”) and inhibition of the actin-capping activity of Eps8, as well as translocation of Eps8 away from actin-rich peripheral regions. In regions where Eps8 is inactivated, actin filaments are able to achieve greater lengths to mediate the formation of filopodia.